Gender-related immune-inflammatory factors, age-related diseases, and longevity.
暂无分享,去创建一个
C. Caruso | D. Lio | S. Vasto | C. Balistreri | G. Candore | F. Listı́ | G. Colonna‐Romano
[1] Aubrey D N J de Grey. Consolidating the mission to defeat aging: a big step forward. , 2008, Rejuvenation research.
[2] J. Nilsen. Estradiol and neurodegenerative oxidative stress , 2008, Frontiers in Neuroendocrinology.
[3] C. Caruso,et al. A scientific approach to anti-ageing therapies: state of the art. , 2008, Current pharmaceutical design.
[4] S. Davidge,et al. Estrogen is a modulator of vascular inflammation , 2008, IUBMB life.
[5] Domenico Lio,et al. Inflammation, genes and zinc in Alzheimer's disease , 2008, Brain Research Reviews.
[6] I. Chaudry,et al. Estrogen: A Novel Therapeutic Adjunct for the Treatment of Trauma-Hemorrhage—Induced Immunological Alterations , 2008, Molecular medicine.
[7] K. Ritchie,et al. Hormonal treatment, mild cognitive impairment and Alzheimer's disease , 2008, International Psychogeriatrics.
[8] D. Mari,et al. Human longevity within an evolutionary perspective: The peculiar paradigm of a post-reproductive genetics , 2008, Experimental Gerontology.
[9] C. Franceschi,et al. The extreme longevity: The state of the art in Italy , 2008, Experimental Gerontology.
[10] C. Caruso,et al. Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision. , 2007, Pharmacogenomics.
[11] C. Franceschi,et al. Pathophysiology of ageing, longevity and age related diseases , 2007, Immunity & Ageing.
[12] R. May. Gender, immunity and the regulation of longevity. , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] R. Straub,et al. The complex role of estrogens in inflammation. , 2007, Endocrine reviews.
[14] B. Nilsson. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes , 2007, Inflammation Research.
[15] J. Rigby,et al. Mortality in relation to sex in the affluent world , 2007, Journal of Epidemiology and Community Health.
[16] C. Franceschi,et al. Immunogenetics, Gender, and Longevity , 2006, Annals of the New York Academy of Sciences.
[17] F. Licastro,et al. Age‐Related Inflammatory Diseases , 2006 .
[18] I. Chaudry,et al. Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. , 2006, Clinics.
[19] A. Członkowska,et al. Gender differences in neurological disease , 2006, Endocrine.
[20] V. W. Henderson,et al. Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research , 2006, Neuroscience.
[21] J. Sastre,et al. Why females live longer than males: control of longevity by sex hormones. , 2005, Science of aging knowledge environment : SAGE KE.
[22] S. Shumaker,et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.
[23] G. Wooten,et al. Postmenopausal estrogen use affects risk for Parkinson disease. , 2004, Archives of neurology.
[24] Robert B Wallace,et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.
[25] C. Franceschi,et al. Association between the HFE mutations and longevity: a study in Sardinian population , 2003, Mechanisms of Ageing and Development.
[26] J. Sastre,et al. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. , 2003, Free radical biology & medicine.
[27] E. Hogervorst,et al. HRT and cognitive decline , 2003 .
[28] G. Perry,et al. Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? , 2002, Neurochemistry International.
[29] J. Vandenbroucke,et al. Female hormones and thrombosis. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[30] C. Franceschi,et al. Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population , 2002, Genes and Immunity.
[31] J. Janowsky,et al. Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.
[32] J. Jolles,et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis , 2000, Neuroscience.
[33] L. Hy,et al. Prevalence of AD among whites , 2000, Neurology.
[34] S. Gandy,et al. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain , 2000, Neurology.
[35] E. Barrett-Connor,et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.
[36] M. Beal,et al. Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.
[37] K. Yaffe,et al. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.
[38] P. Shughrue,et al. Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system , 1997, The Journal of comparative neurology.
[39] R. Brinton,et al. 17 β-Estradiol Enhances the Outgrowth and Survival of Neocortical Neurons in Culture , 1997, Neurochemical Research.
[40] V. Henderson. Estrogen Replacement Therapy for the Prevention and Treatment of Alzheimer’s Disease , 1997 .
[41] J. Trojanowski,et al. Strategies for Improving the Postmortem Neuropathological Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[42] M. Mattson,et al. Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.
[43] J. Simpkins,et al. Estradiol enhances brain glucose uptake in ovariectomized rats , 1995, Brain Research Bulletin.
[44] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[45] P. Bédard,et al. ŒSTROGENS AND EXTRAPYRAMIDAL SYSTEM , 1977, The Lancet.
[46] X. Qiao,et al. Sex steroids and vascular responses in hypertension and aging. , 2008, Gender medicine.
[47] R. Brinton. Impact of Estrogen Therapy on Alzheimer’s Disease , 2004, CNS drugs.
[48] T. Di Paolo,et al. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. , 2002, Journal of psychiatry & neuroscience : JPN.
[49] C. Caruso,et al. Analysis of hemochromatosis gene mutations in the Sicilian population: implications for survival and longevity. , 2002, Archives of gerontology and geriatrics. Supplement.
[50] R. Traystman,et al. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. , 2000, Stroke.
[51] H. Matsuda,et al. Estrogen Increases Cerebral and Cerebellar Blood Flows in Postmenopausal Women , 1995 .
[52] C. Toran-Allerand. Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2003-1462 Minireview: A Plethora of Estrogen Receptors in the Brain: Where Will It End? , 2022 .